Agilent Raises Outlook on Q3 Growth

Agilent Technologies reported strong Q3 FY2025 results, with revenue of $1.74 billion, up 6.1% core year-over-year, and non-GAAP EPS of $1.37, both exceeding guidance. The company raised its full-year revenue outlook to $6.91 billion-$6.93 billion, driven by its fifth consecutive quarter of accelerating core revenue growth and broad-based demand, particularly in pharmaceutical and chemical end markets, supported by a robust innovation pipeline. Despite a 230 basis point decline in operating margins due to tariff and logistics costs, management articulated a clear mitigation strategy via its Ignite program for FY2026, signaling confidence in sustained momentum and long-term growth.

Analysis

Agilent Technologies (A) demonstrated significant commercial momentum in its Q3 FY2025 results, reporting a fifth consecutive quarter of accelerating core revenue growth. Revenue reached $1.74 billion, a 6.1% year-over-year core increase, while non-GAAP EPS hit $1.37, both surpassing prior guidance. This top-line strength was broad-based, led by double-digit expansion in the critical Pharma and Chemicals & Advanced Materials end markets, which grew 9-10% respectively. The company's innovation pipeline is a key driver, with the Infinity Tree LC platform delivering mid-teens growth and the NASD CDMO business expanding over 20%. Despite this robust performance, operating margins contracted by 230 basis points year-over-year to 25.1%, predominantly due to $70 million in tariff and logistics costs. However, management has confidently raised its full-year FY2025 revenue guidance by $150 million to a range of $6.91-$6.93 billion and is guiding for a 230 basis point sequential margin improvement in Q4, signaling that the margin pressures are being actively managed. The company's 'Ignite' program is on track to fully mitigate tariff impacts by FY2026, suggesting a clear path back to improved profitability.

Key Decisions for Investors

• Investors should weigh the strong top-line momentum and raised full-year guidance against the significant near-term margin pressure from tariffs, making execution on the guided Q4 margin recovery a critical catalyst to watch.
• Monitor the progress of the 'Ignite' program and any management commentary on pricing actions and supply chain adjustments, as the successful mitigation of tariff costs by FY2026 is key to unlocking future earnings leverage.
• For those with a long-term horizon, focus on the performance of new product platforms like Infinity Tree LC and Pro IQ LCMS, as their continued market adoption and contribution to the six-consecutive-quarter streak of instrument book-to-bill above one validates the company's innovation-led growth strategy.